Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Ko‐Lin Kuo"'
Publikováno v:
Tzu-Chi Medical Journal, Vol 34, Iss 4, Pp 394-401 (2022)
Uremic pruritus (UP) is common in the late stages of chronic kidney disease. Currently, there is a lack of effective treatment for UP. Limited evidence exists on the therapeutic effect of omega-3 fatty acid (O3FA). The aim of this study was to evalua
Externí odkaz:
https://doaj.org/article/f98a8005a4d54f79b54becba181bd150
Autor:
Ko-Lin Kuo, Jia-Sin Liu, Ming-Huang Lin, Chih-Cheng Hsu, Der-Cherng Tarng, the Taiwan Society of Nephrology Renal Registry Data System Research Group
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract In 1996, the National Health Insurance Administration of Taiwan applied a restrictive reimbursement criteria for erythropoiesis-stimulating agents (ESAs) use in patients with chronic kidney disease. The maximal ESAs dosage allowed by insuran
Externí odkaz:
https://doaj.org/article/fe78cba003f442b5bb03918bf17f5d39
Publikováno v:
Pharmaceutics, Vol 15, Iss 10, p 2380 (2023)
Patients with chronic kidney disease (CKD) have a higher prevalence of peripheral arterial disease (PAD), and endothelial progenitor cells (EPCs) play a pivotal role. We examined the impact of granulocyte colony-stimulating factor (G-CSF) on EPC func
Externí odkaz:
https://doaj.org/article/170cd04aa2af4b3091c82c77fb352dde
Publikováno v:
Pharmaceutics, Vol 15, Iss 6, p 1714 (2023)
(1) Background: Increasing attention has been given to applying nanosized iron oxide nanoparticles (IOPs) to treat iron deficiency anemia (IDA). Chronic kidney disease (CKD) patients who suffer from IDA often need long-term iron supplements. We aim t
Externí odkaz:
https://doaj.org/article/cca49abbaa6a4636839c6316c6ca793a
Publikováno v:
Tzu-Chi Medical Journal, Vol 33, Iss 4, Pp 350-358 (2021)
Uremic pruritus (UP), also called chronic kidney disease-associated pruritus (CKD-aP), is a bothersome symptom that causes sleep disturbance, anxiety, depression, and reduced quality of life. Pruritus often occurs in patients with end-stage renal dis
Externí odkaz:
https://doaj.org/article/542fa2ee75f14d7796c9c90e2283af66
Autor:
Yi-Chou Hou, Hui-Fen Huang, Wen-Hsin Tsai, Sin-Yi Huang, Hao-Wen Liu, Jia-Sin Liu, Ko-Lin Kuo
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
IntroductionDiabetes mellitus (DM) is a pathological hyperglycemic state related to the dysregulation of insulin. Chronic kidney disease (CKD) is a common chronic complication in diabetic patients. A vegetarian diet could be one of the preventive str
Externí odkaz:
https://doaj.org/article/78f8118fa7a74b6bb96b24e8565c6f37
Autor:
Ping-Hsun Lu, Chien-Wei Tseng, Jing-Ling Lee, En-Yu Lee, Yu-Ping Lin, I-Hsin Lin, Min-Chien Yu, Kuo-Cheng Lu, Ko-Lin Kuo
Publikováno v:
Pharmacological Research - Modern Chinese Medicine, Vol 2, Iss , Pp 100024- (2022)
Background: SARS-CoV-2 has led to a sharp increase in the number of hospitalizations and deaths from pneumonia and multiorgan disease worldwide; therefore, SARS-CoV-2 has become a global health problem. Supportive therapies remain the mainstay treatm
Externí odkaz:
https://doaj.org/article/4b7508cdf1a5433388c5e1480e6e4648
Publikováno v:
Antioxidants, Vol 12, Iss 2, p 477 (2023)
Dialysis prevents death from uremia in patients with end-stage renal disease (ESRD). Nevertheless, during hemodialysis, circulating levels of di-(2-ethylhexyl) phthalate (DEHP) are increased due to phthalates leaching from medical tubes. Statins are
Externí odkaz:
https://doaj.org/article/bb0b007affb6422592db7536cfdab3e2
Publikováno v:
Tzu-Chi Medical Journal, Vol 32, Iss 1, Pp 65-69 (2020)
Objective: Nonalcoholic fatty liver (NAFLD) and chronic kidney disease (CKD) share common pathogenic mechanisms and risk factors. The relationship between in NAFLD and CKD remains controversial. We aim to assess the association between NAFLD and CKD.
Externí odkaz:
https://doaj.org/article/bd613cf068954929890f5ff0dacad6af
Indoxyl Sulfate Alters the Humoral Response of the ChAdOx1 COVID-19 Vaccine in Hemodialysis Patients
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1378 (2022)
Background and aims: Vaccination for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) is strongly recommended. The efficacy of SARS-CoV-2 vaccine for patients with end-stage renal disease is low. Indoxyl sulfate (IS) is a representative pr
Externí odkaz:
https://doaj.org/article/b63defb40e50418f8ffb6b964d2fb66e